FDA recall, , Moderate risk
Inventia Healthcare Chlorthalidone Tablets
Chlorthalidone Tablets fail dissolution specifications.
Summary by Recall Canary from the FDA notice
What happened
Inventia Healthcare Limited, of Kalyan, India, recalled Chlorthalidone Tablets, USP, 25 mg, in 100- and 1000-tablet bottles, because the product failed dissolution specifications. The recall began June 5, 2026, and was added to the FDA's Enforcement Report on June 12, 2026, with classification on June 22, 2026. The product was distributed nationwide in the U.S. by Risiong Pharma Holdings, Inc., of East Brunswick, NJ. The recall involved 11,460 bottles.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the list below, then check the codes the FDA notice also names.
An NDC (National Drug Code) is usually printed on the drug's label.
Chlorthalidone Tablets, USP, 25 mg
- NDC
- 64980-599-01
- 64980-599-10
- Lot code
- RISA24001
- RISB24002
From the FDA notice
NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
Recall details
- Company began the recall
- Sold in
U.S. Nationwide.
- Company
- Inventia Healthcare LimitedKalyan, India
- Hazard
- Drug dissolving problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99136
- Recall number
- D-0610-2026
- Quantity recalled
- 11,460 bottles
All recalls from Inventia Healthcare Limited
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Listed on Recall Canary
Classified by FDA
In FDA's weekly enforcement report
Summary updated
